Abstract
Data from studies of 337 children and 1606 young adults are summarized to identify the major causes of stroke in these age groups. In children under 15 years of age, stroke occurs in patients with congenital heart disease, nonatherosclerotic vasculopathies, infection, and hematologic defects like sickle cell disease. In patients 15 to 35 years of age, dissection, cardioembolism, nonatheroslerotic vasculopathies, and prothrombotic states cause a significant percentage of strokes. In adults over 35 years of age, traditional atherosclerotic risk factors predominate. Lifestyle choices (eg, cigarette smoking, alcohol consumption, and illicit drug use) can significantly increase the rate of stroke among young adults in a community. Limited access to healthcare may increase the role of infectious disease and peripartum complications.
Similar content being viewed by others
References and Recommended Reading
Rozenthul-Sorokin N, Ronen R, Tamir A, et al.: Stroke in the young in Israel. Stroke 1996, 27:838–841.
Kittner SJ, McCarter RJ, Sherwin R, et al.: Black-white differences in stroke risk among young adults. Stroke 1993, 24:I13-I15.
Broderick J, Talbot GT, Prenger E, et al.: Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 1993, 8:250–255.
Ferrera PC, Curran CB, Swanson H: Etiology of pediatric ischemic stroke. Am J Emerg Med 1997, 15:671–679.
Bevan H, Sharma K, Bradley W: Stroke in young adults. Stroke 1990, 21:382–386.
Taylor TN, Davis PH, Torner JC, et al.: Lifetime cost of stroke in the United States. Stroke 1996, 27:1459–1466.
Kerr LM, Anderson DM, Thompson JA, Lyver SM: Ischemic stroke in the young: evaluation and age comparison of patients six months to thirty-nine years. J Child Neurol 1993, 8:266–270.
Kittner SJ, Stern BJ, Wozniak MA, et al.: Cerebral infarction in young adults. Neurology 1998, 50:890–894.
Williams LS, Garg BP, Cohen M, et al.: Subtypes of ischemic stroke in children and young adults. Neurology 1997, 49:1541–1545. One of the more thoughtful series on strokes in young adults and children.
Barinagarrementeria F, Gonzalez-Duarte A, Miranda L, Cantu C: Cerebral infarction in young women: analysis of 130 cases. Eur Neurol 1998, 40:228–233.
Neto JS, Santos AC, Fabio SC, Sakamoto AC: Cerebral infarction in patients aged 15 to 40 years. Stroke 1996, 27:2016–2019.
You RX, McNeil JJ, O’Malley HM, et al.: Risk factors for stroke due to cerebral infarction in young adults. Stroke 1997, 28:1913–1918.
Lanzino G, Andreoli A, DiPasquale G, et al.: Etiopathogenesis and prognosis of cerebral ischemia in young adults. A survey of 155 treated patients. Acta Neurol Scand 1991, 84:321–325.
Awada A: Stroke in Saudi Arabian young adults: a study of 120 cases. Acta Neurol Scand 1994, 89:323–328.
Koul R, Motta A, Razdan S: Epidemiology of young strokes in rural Kashmir, India. Acta Neurol Scand 1990, 82:1–3.
Kwon SU, Kim JS, Lee MC: Ischemic stroke in Korean young adults. Acta Neurol Scand 2000, 101:19–24.
Riikonen R, Santavuori P: Hereditary and acquired risk factors for childhood stroke. Neuropediatrics 1994, 227–233.
Mancini J, Girard N, Chabrol B, et al.: Ischemic cerebrovascular disease in children: retrospective study of 35 patients. J Child Neurol 1997, 12:193–199.
Giroud M, Lemesle M, Madinier G, et al.: Stroke in children under 16 years of age. Clinical and etiological difference with adults. Acta Neurol Scand 1997, 96:401–406.
Al-Sulaiman A, Bademosi O, Ismail H, Magboll G: Stroke in Saudi children. J Child Neurol 1999, 14:295–298.
Nagaraja D, Verma A, Taly AB, et al.: Cerebrovascular disease in children. Acta Neurol Scand 1994, 90:251–255.
Kristensen B, Malm J, Carlberg B, et al.: Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 1997, 28:1702–1709.
Petitti DB, Sidney S, Quesenberry C, Bernstein A: Stroke and cocaine or amphetamine use. Epidemiology 1998, 9:596–600.
Sloan MA, Kittner SJ, Feeser BR, et al.: Illicit drug-associated ischemic stroke in the Baltimore-Washington Young Stroke Study. Neurology 1998, 19:1688–1693.
Kunst AE, del Rios M, Groenhof F, Mackenback JP, and European Union Working Group on Socioeconomic Inequalities in Health. Socioeconomic inequalities in stroke mortality among middle-aged men. An international overview. Stroke 1998, 29:2285–2291.
Casper M, Wing S, Strogatz D, et al.: Antihypertensive treatment and US trends in stroke mortality, 1962 to 1980. Am J Public Health 2000, 82:1600–1606.
Sacco RL, Boden-Albala B, Gan R, et al.: Stroke incidence among white, black, and Hispanic residents of an urban community. Am J Epidemiol 1998, 147:259–268.
Gillum RF: Stroke mortality in blacks. Stroke 1999, 30:1711–1715.
Stewart JA, Dundas R, Howard RS, et al.: Ethnic differences in incidence of stroke: prospective study with stroke register. BMJ 1999, 318:967–971.
Kirkham FJ: Stroke in childhood. Arch Dis Child 1999, 81:85–89.
Lidegaard O, Soe M, Andersen MV: Cerebral thromboembolism among young women and men in Denmark 1977–1982. Stroke 1986, 17:670–675.
Masuda J, Ogata J, Yamaguchi T: Moyamoya disease. In In Stroke Pathophysiology, Diagnosis, and Management, edn 3. Edited by Barnett HJM, Mohr JP, Stein BM, Yatsu FM. New York: Churchill Livingstone; 1998:815–832. A very lucid and comprehensive review of Moyamoya.
Guillon B, Levy C, Bousser MG: Internal carotid artery dissection: an update. J Neurol Sci 1998, 153:146–158.
Chang AJ, Mylonakis E, Karanasias P, et al.: Spontaneous bilateral vertebral artery dissections: case report and literature review. Mayo Clin Proc 1999, 74:893–896.
Barinagarrementeria F, Amaya LE, Cantu C: Causes and mechanisms of cerebellar infarction in young patients. Stroke 1997, 28:2400–2404.
Sloan MA, Kittner SJ, Rigamonti D, Price TR: Occurrence of stroke associated with use/abuse of drugs. Neurology 1991, 41:1358–1364.
Grau AJ, Buggle F, Hacke W: Infectious diseases as a cause and risk factor for cerebrovascular ischemia. Nervenarzt 1996, 67:639–649.
Mavrommatis AC, Theodoridis T, Orfanidou A, et al.: Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 2000, 28:451–457.
Simon RP: Neurosyphilis. Neurology 1994, 44:2228–2229.
Tyler KL, Sandberg E, Baum KF: Medial medullary syndrome and meningovascular syphilis: a case report in an HIV-infected man and a review of the literature. Neurology 1994, 44:2231–2235.
Fishman RA: CSF findings in diseases of the nervous system. In Cerebrospinal Fluid in Diseases of the Nervous System, edn 2. Edited by Fishman RA. Philadelphia: WB Saunders; 1992:253–344.
Case Records of the Massachusetts General Hospital. Case 36-1996. N Engl J Med 2000, 335:1587–1595.
Dubrovsky T, Curless R, Scott G, et al.: Cerebral aneurysmal arteriopathy in childhood AIDS. Neurology 1998, 51:560–565.
Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, et al.: Neurologic complications of the reactivation of Varicella-zoster virus. N Engl J Med 2000, 342:635–645.
Preul MC, Cendes F, Just N, Mohr G. Intracranial aneurysms and sickle cell anemia: multiplicity and propensity for the vertebrobasilar territory. Neurosurgery 1998, 42:971–977.
Ohene-Frempong K, Weiner SJ, Sleeper LA, and Cooperative Study of Sickle Cell Disease. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998, 91:288–294.
Earley CJ, Kittner SJ, Feeser BR, et al.: Stroke in children and sickle-cell disease. Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998, 51:169–176.
Kinney TR, Sleeper LA, Wang WC, et al.: Silent cerebral infarcts in sickle cell disease: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 1999, 103:640–645.
Armstrong FD, Thompson RJ Jr, Wang W, et al.: Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics 1996, 97:864–870.
Nietert PJ, Abboud MR, Silverstein MD, Jackson SM: Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood 2000, 95:3057–3064.
Ware RE, Zimmerman SA, Schulz WH: Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood 1999, 94:3022–3026.
Adams RJ, McKie VC, Hsu L, et al.: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998, 339:5–11. Landmark paper that identifies patients with sickle cell disease who are at high risk for stroke and require immediate intervention.
DeStefano V, Finazzi G, Mannucci PM: Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 2000, 87:3531–3544.
Martinez HR, Rangel-Guerra RA, Marfil LJ: Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults. Stroke 1993, 24:19–25.
Reitsma PH, Bernardi F, Doig RG, et al.: Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thromb Hemost 1995, 73:876–879.
Koh S, Chen LS: Protein C and S deficiency in children with ischemic cerebrovascular accident. Pediatr Neurol 1997, 17:319–321.
Dahlback B: Resistance to activated protein C, the Arg506 to Gln mutation in the Factor V gene, and venous thrombosis. Functional tests and DNA-based assays, Pros and Cons. Thromb Haemost 1995, 73:739–742.
Nabavi DG, Junker R, Wolff E, et al.: Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study of 225 patients. J Neurol 1998, 245:653–658.
Rosendaal FR: Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost 1997, 78:1–6.
Frenkel EP, Bick RL: Prothrombin G20210A gene mutation, heparin cofactor II defects, primary essential thrombocythemia, and thrombohemorrhagic manifestations. Sem Thromb Hemost 1999, 25:375–386.
Brey RL, Hart RG, Sherman DG, Tegeler CH: Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990, 40:1190–1196.
Schoning M, Klein R, Krageloh-Mann I, et al.: Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood. Neuropediatrics 1994, 25:8–14.
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988, 8(Suppl 7):1–96.
Welch KM, Tatemichi TK, Morh JP: Migraine and stroke. In Stroke Pathophysiology, Diagnosis, and Management, edn 3. Edited by Barnett HJM, Mohr JP, Stein BM, Yatsu FM. New York: Churchill Livingstone; 1998:845–867.
D’Anglejan-Chatillon J, Ribeiro V, Youl BD, Bousser MG: Migraine—a risk factor for dissection of cervical arteries. Headache 1989, 29:560–561.
Tzourio C, El Amrani M, Robert L, Alperovitch A: Serum elastase activity is elevated in migraine. Ann Neurol 2000, 47:648–651.
Solomon S, Lipton RB, Harris PY: Arterial stenosis in migraine: spasm or arteriopathy? Headache 1990, 30:52–61.
Shuaib A: Stroke from other etiologies masquerading as migraine-stroke. Stroke 1991, 22:1068–1074.
Bousser MG, Tournier-Lasserve E: Summary of the proceedings of the First International Workshop on CADASIL. Paris, May 19–21, 1993. Stroke 1994, 25:704–707.
Ruchoux MM, Chabriat H, Bousser MG, et al.: Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke 1994, 25:2291–2292.
Chabriat H, Tournier-Lasserve E, Bousser MG: Vasculopathies. In Genetics of Cerebrovascular Disease. Edited by Alberts MJ. Armonk, NY: Futura Publishing; 1999:195–208. Lucid, comprehensive summary.
Hutchison M, O’Riordan J, Javed M, et al.: Familial hemiplegic migraine and autosomal dominant arteriopathy with leukoencephalopathy (CADASIL). Ann Neurol 2000, 38:817–824.
Yoo JH, Chung CS, Kang SS: Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke 1998, 29:2478–2483.
Kittner SJ, Giles WH, Macko RF, et al.: Homocyst(e)ine and risk of cerebral infarction in a biracial population. The Stroke Prevention in Young Women Study. Stroke 1999, 30:1554–1560.
Domagala TB, Undas A, Libura M, Szczeklik A: Pathogenesis of vascular disease in hyperhomocysteinemia. J Cardiovasc Risk 1998, 5:239–247.
Andrews PI, Ryan MM, Kandt RS: Genetic causes of pediatric stroke. In Genetics of Cerebrovascular Disease. Edited by Alberts MJ. Armonk, NY: Futura Publishing; 1999:261–311. Lucid and comprehensive survey.
Mandel H, Brenner B, Berant M, et al.: Coexistence of hereditary homocystinuria and factor V Leiden-effect on thrombosis. N Engl J Med 1996, 334:763–768.
Perna AF, Castaldo P, De Santo NG, et al.: Homocysteine and chronic renal failure. Miner Electrolyte Metab 1999, 25:279–285.
Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995, 274:1049–1057.
Kristensen B, Malm J, Nilsson TK, et al.: Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. Stroke 1999, 30:974–980.
McCully KS: Vascular pathology of homocystinemia: implications for the pathogenesis of atherosclerosis. Am J Pathol 1969, 56:111–128.
Dudman NP, Wilcken DE, Wang J, et al.: Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 1993, 13:1253–1260.
Kittner SJ, Stern BJ, Feeser BR, et al.: Pregnancy and the risk of stroke. N Engl J Med 1996, 335:768–774.
Donaldson JO: Cerebrovascular disease. In Neurology of Pregnancy. Edited by Donaldson JO. London: WB Saunders; 1989:137–184.
Burkman RT: The estrogen component of OCs: cardiovascular benefits and risks. Int J Fertil 1997, 42(suppl bd1):145–157.
Petitti DB, Sidney S, Bernstein A, et al.: Stroke in users of low-dose oral contraceptives. N Engl J Med 1996, 335:8–15.
Marini C, Totaro R, Carolei A, and National Research Council Group. Long-term prognosis of cerebral ischemia in young adults. Stroke 1999, 30:2320–2325. Defines the actual outcome of stroke in young adults, which is sadly less optimistic than the short-term assessments made in other series.
Abram HS, Knepper LE, Warty VS, Painter MJ: Natural history, prognosis, and lipid abnormalities of idiopathic ischemic childhood stroke. J Child Neurol 1996, 11:276–282.
Dennis M, Spiegler BJ, Hetherington R: New Survivors for the new millennium: cognitive risk and reserve in adults with childhood brain insults. Brain Cogn 2000, 42:102–105.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bendixen, B.H., Posner, J. & Lango, R. Stroke in young adults and children. Curr Neurol Neurosci Rep 1, 54–66 (2001). https://doi.org/10.1007/s11910-001-0077-8
Issue Date:
DOI: https://doi.org/10.1007/s11910-001-0077-8